Cencora, Inc.
COR- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001140859
In the last 90 days, Cencora, Inc. insiders filed 0 open-market purchases and 3 sales; 1,352 institutions reported holding it in 13F filings for Q2 2026, worth $51.8B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.40M in total
- 3
- 13F holdersQ2 2026, −72 vs. previous quarter
- 1,352
- 13F valueReported value at the end of Q2 2026
- $51.8B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding COR, Q2 2026
No superinvestor reported holding COR at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Cencora, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 (view filing)3:58 PM ET | Sep 16 | 1 day | Greenberg Lon RDirector | SSale | −1.28K | $321.30 | −$411.3K | −7.0%17.1K after | |
| Sep 2, 2026 (view filing)4:00 PM ET | Sep 1 | 1 day | Krikorian LazarusSVP & Chief Accounting Officer | SSale | −985 | $325.97 | −$321.1K | −5.7%16.2K after | 10b5-1 |
| Aug 25, 2026 (view filing)4:14 PM ET | Aug 24 | 1 day | Campbell Elizabeth SExecutive Vice President | SSale | −11.3K | $324.12 | −$3.66M | −36.7%19.5K after | |
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Tyler Lauren MDirector | PPurchase | +550 | $270.23 | +$148.6K | +14.4%4.36K after | |
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Durcan Dermot MarkDirector | PPurchase | +4.00K | $274.19 | +$1.10M | +14.4%31.8K after | |
| May 28, 2026 (view filing) | May 28 | Same day | Durcan Dermot MarkDirector | PPurchase | +4.00K | $266.26 | +$1.07M | +16.8%27.8K after | |
| Feb 24, 2026 (view filing) | Feb 20 | 4 days | Mauch Robert P.President & CEO | SSale | −3.76K | $358.94 | −$1.35M | −5.4%65.4K after | 10b5-1 |
| Feb 20, 2026 (view filing) | Feb 18 | 2 days | Mauch Robert P.President & CEO | SSale | −1.33K | $359.46 | −$479.2K | −2.0%65.4K after | 10b5-1 |
| Jan 22, 2026 (view filing) | Jan 20 | 2 days | Mauch Robert P.President & CEO | SSale | −5.10K | $354.73 | −$1.81M | −7.1%66.7K after | 10b5-1 |
| Dec 22, 2025 (view filing) | Dec 19 | 3 days | Campbell Elizabeth SExecutive Vice President | SSale | −3.35K | $342.10 | −$1.15M | −12.3%23.9K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Cencora, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18,213,783 | $5.15B | 0.08% | −1,729,854−8.7% | Reduced |
| Vanguard Capital Management LLC | 12,378,943 | $3.50B | 0.07% | +65,484+0.5% | Added |
| Vanguard Portfolio Management LLC | 9,611,756 | $2.72B | 0.12% | +21,342+0.2% | Added |
| State Street Corp | 9,273,983 | $2.62B | 0.08% | +83,432+0.9% | Added |
| T. Rowe Price Investment Management, Inc. | 7,410,910 | $2.10B | 1.37% | +1,116,614+17.7% | Added |
| Price T Rowe Associates Inc | 7,132,687 | $2.02B | 0.20% | −191,019−2.6% | Reduced |
| JPMorgan Chase & Co | 5,943,657 | $1.67B | 0.10% | +1,058,179+21.7% | Added |
| Geode Capital Management, LLC | 5,454,888 | $1.54B | 0.08% | −111,156−2.0% | Reduced |
| Boston Partners | 4,868,782 | $1.38B | 1.23% | +385,965+8.6% | Added |
| Wellington Management Group LLP | 4,559,761 | $1.29B | 0.22% | +11,149+0.2% | Added |